Evidence map›Paper›PMID 32336172›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2020

Synthesis and carbonic anhydrase activating properties of a series of 2-amino-imidazolines structurally related to clonidine

Niccolò Chiaramonte, Soumia Maach, Caterina Biliotti, Andrea Angeli, Gianluca Bartolucci, Laura Braconi, Silvia Dei, Elisabetta Teodori, Claudiu T Supuran, Maria Novella Romanelli

Abstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Coumarin carbonic anhydrase inhibitors from natural sources.Journal of enzyme inhibition and medicinal chemistry · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Niccolò ChiaramonteSection of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Sesto Fiorentino, Italy.
Soumia MaachSection of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Sesto Fiorentino, Italy.
Caterina BiliottiSection of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Sesto Fiorentino, Italy.
Andrea AngeliSection of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Sesto Fiorentino, Italy.ORCID http://orcid.org/0000-0002-1470-7192
Gianluca BartolucciSection of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Sesto Fiorentino, Italy.ORCID http://orcid.org/0000-0002-5631-8769
Laura BraconiSection of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Sesto Fiorentino, Italy.
Silvia DeiSection of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Sesto Fiorentino, Italy.ORCID http://orcid.org/0000-0003-0898-7148
Elisabetta TeodoriSection of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Sesto Fiorentino, Italy.ORCID http://orcid.org/0000-0002-9705-3875
Claudiu T SupuranSection of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Sesto Fiorentino, Italy.ORCID http://orcid.org/0000-0003-4262-0323
Maria Novella RomanelliSection of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Sesto Fiorentino, Italy.ORCID http://orcid.org/0000-0002-5685-3403

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Carbonic Anhydrase (CA, EC 4.2.1.1) activating properties of histamine have been known for a long time. This compound has been extensively modified but only in few instances the imidazole ring has been replaced with other heterocycles. It was envisaged that the imidazoline ring could be a bioisoster of the imidazole moiety. Indeed, we report that clonidine, a 2-aminoimidazoline derivative, was found able to activate several human CA isoforms (hCA I, IV, VA, VII, IX, XII and XIII), with potency in the micromolar range, while it was inactive on hCA II. A series of 2-aminoimidazoline, structurally related to clonidine, was then synthesised and tested on selected hCA isoforms. The compounds were inactive on hCA II while displayed activating properties on hCA I, VA, VII and XIII, with K

Indexed as

Carbonic Anhydrase InhibitorsCarbonic AnhydrasesClonidineDose-Response Relationship, DrugHumansImidazolesIsoenzymesMolecular StructureStructure-Activity Relationship2-aminoimidazoloneCarbonic Anhydrase InhibitorsCarbonic AnhydrasesClonidineImidazolesIsoenzymesactivatorCarbonic anhydraseclonidinehistamineimidazoline

Identifiers

PMID32336172
PMCPMC7241460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.